Vivien C. Nielsen, Ph.D. assists in prosecuting patents in the pharmaceutical, chemical sciences, and biotechnology industry areas. Dr. Nielsen is equally poised in providing due diligence related to patent strategy and intellectual property litigation matters for clients.
- Prepared and prosecuted patent applications relating to biologics, small-molecule therapeutics, pharmaceutical formulations, and personal care products
- Analyzed freedom-to-operate issues for a large pharmaceutical company
- Assessed patentability of a new drug indication for a leading research university
Dr. Nielsen has assisted clients with intellectual property in a wide variety of disciplines, including the following:
- Drug Discovery and Development
- Pharmaceutical Formulations
- Drug Delivery Systems
- Cancer Therapeutics
- Product Development
Background and Credentials
Dr. Nielsen obtained her J.D. from the University of Michigan Law School and is registered to practice with the U.S. Patent and Trademark Office. As a law student, Dr. Nielsen was a Dean’s Scholar and a Contributing Editor to the Michigan Telecommunications and Technology Law Review. She also served as President of the Intellectual Property Students Association.
Dr. Nielsen earned her Ph.D. in pharmaceutical sciences from the University of Michigan. Her doctoral research focused on reducing drug resistance in cancer cells. As a graduate student, she was awarded fellowships from the NIH, PhRMA Foundation, and American Foundation for Pharmaceutical Education. Dr. Nielsen received a B.S. in biology with a minor in chemistry from Duke University.
In addition to her academic research, her previous experience working in R&D for large corporations such as Pfizer, Avon, and Unilever has given Dr. Nielsen technical knowledge valuable for achieving patent protection for a broad range of consumer products.
- The University of Michigan Law School (J.D.)
- University of Michigan (Ph.D.)
- Pharmaceutical Sciences
- Duke University (B.S.)
- U.S. Patent and Trademark Office
Publications and Presentations
- “Getting From Bench-to-Bedside,” American Chemical Society National Meeting, March 25, 2015.
- “Induced Patent Infringement Breaks Free from Direct Infringement: The Implications for Bioprocessing,” Co-Author, BioProcessing Journal, Winter 2012/2013.
- “The Limited Benefits of Product-By-Process Claims,” Co-Author, Intellectual Property Today. 2009, 16(12), 22-23.
- V.Y. Chen, M.M. Posada, L. Zhao and G.R. Rosania. “Rapid doxorubicin efflux from the nucleus of drug-resistant cancer cells following extracellular drug clearance.” Pharmaceutical Research. 2007, 24(11), 2156-2167.
- V.Y. Chen, M.M. Posada, L.L. Blazer, T. Zhao and G.R. Rosania. “The role of the VPS4a-exosome pathway in the intrinsic egress route of a DNA-binding anticancer agent.” Pharmaceutical Research. 2006, 23(8), 1687-1695.
Click here to additional Publications and Presentations.
Community and Professional Involvement
- American Association of Pharmaceutical Scientists (AAPS)
- Intellectual Property Law Association of Chicago (IPLAC)